Differential protein‐coding gene and long noncoding RNA expression in smoking‐related lung squamous cell carcinoma

Abstract

BackgroundCigarette smoking is one of the greatest preventable risk factors for developing cancer, and most cases of lung squamous cell carcinoma (lung SCC) are associated with smoking. The pathogenesis mechanism of tumor progress is unclear. This study aimed to identify biomarkers in smoking‐related lung cancer, including protein‐coding gene, long noncoding RNA, and transcription factors.MethodsWe selected and obtained messenger RNA microarray datasets and clinical data from the Gene Expression Omnibus database to identify gene expression altered by cigarette smoking. Integrated bioinformatic analysis was used to clarify biological functions of the identified genes, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, the construction of a protein–protein interaction network, transcription factor, and statistical analyses. Subsequent quantitative real‐time PCR was utilized to verify these bioinformatic analyses.ResultsFive hundred and ninety‐eight differentially expressed genes and 21 long noncoding RNA were identified in smoking‐related lung SCC. GO and KEGG pathway analysis showed that identified genes were enriched in the cancer‐related functions and pathways. The protein–protein interaction network revealed seven hub genes identified in lung SCC. Several transcription factors and their binding sites were predicted. The results of real‐time quantitative PCR revealed that AURKA and BIRC5 were significantly upregulated and LINC00094 was downregulated in the tumor tissues of smoking patients. Further statistical analysis indicated that dysregulation of AURKA, BIRC5, and LINC00094 indicated poor prognosis in lung SCC.ConclusionProtein‐coding genes AURKA, BIRC5, and LINC00094 could be biomarkers or therapeutic targets for smoking‐related lung SCC.

Long non‐coding RNA OIP5‐AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR‐378a‐3p

“…Study of miRNAs has dominated the field of noncoding RNA regulation in the past decade . Recently, more and more studies have indicated that lncRNAs provide a growth advantage to malignant cells, resulting in progressive and uncontrolled tumor growth . This provides us with new directions for cancer treatment.…”

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

“…Compared to normal lung tissue, linc01433 is significantly overexpressed and promotes migration and invasion in NSCLC . LINC00094 is highly expressed in lung cancer tissues and could be a molecular target for therapy for smoking‐related lung cancer . In recent years, emerging evidence has confirmed the role of lncRNAs in drug resistance …”

The role of LINC00094/miR‐224‐5p (miR‐497‐5p)/Endophilin‐1 axis in Memantine mediated protective effects on blood‐brain barrier in AD microenvironment

“…15 Moreover, microarray analysis showed that LINC00094 is down-regulated in MEM-incubated cells. 15 Moreover, microarray analysis showed that LINC00094 is down-regulated in MEM-incubated cells.…”

“…It has been reported that LINC00094 may as a prognostic biomarker of lung cancer. 15 Moreover, microarray analysis showed that LINC00094 is down-regulated in MEM-incubated cells. However, the regulatory role and potential mechanisms of LINC00094 affecting the BBB permeability have not been investigated.…”